SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-13-001504
Filing Date
2013-11-07
Accepted
2013-11-07 11:58:41
Documents
6
Period of Report
2013-11-07

Document Format Files

Seq Description Document Type Size
1 6-K v359629_6k.htm 6-K 12647
2 EXHIBIT 99.1 v359629_ex99-1.htm EX-99.1 108045
3 EXHIBIT 99.2 v359629_ex99-2.htm EX-99.2 150330
4 EXHIBIT 99.3 v359629_ex99-3.htm EX-99.3 28527
5 EXHIBIT 99.4 v359629_ex99-4.htm EX-99.4 11009
6 EXHIBIT 99.5 v359629_ex99-5.htm EX-99.5 10943
  Complete submission text file 0001279569-13-001504.txt   322616
Mailing Address 6TH FLOOR 6190 AGRONOMY RD. VANCOUVER A1 V6T 1Z3
Business Address 6TH FLOOR 6190 AGRONOMY RD. VANCOUVER A1 V6T 1Z3 1-604-677-6905
Cardiome Pharma Corp (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 131199400
SIC: 2834 Pharmaceutical Preparations